Sumitomo Mitsui Trust Group Inc. Has $41.51 Million Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Sumitomo Mitsui Trust Group Inc. increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 451,544 shares of the medical device company’s stock after buying an additional 7,681 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Cooper Companies were worth $41,510,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Ashton Thomas Securities LLC acquired a new stake in shares of Cooper Companies in the third quarter worth $25,000. Covestor Ltd raised its stake in Cooper Companies by 144.9% during the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after acquiring an additional 200 shares in the last quarter. Brown Brothers Harriman & Co. lifted its holdings in Cooper Companies by 191.0% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after purchasing an additional 275 shares during the last quarter. Friedenthal Financial bought a new position in shares of Cooper Companies in the third quarter valued at approximately $50,000. Finally, Cromwell Holdings LLC acquired a new position in Cooper Companies in the third quarter worth $52,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

COO has been the topic of several research analyst reports. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Citigroup cut their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Wells Fargo & Company lifted their target price on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Morgan Stanley reduced their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Trading Up 0.1 %

Shares of NASDAQ:COO opened at $93.63 on Tuesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The Cooper Companies, Inc. has a 52-week low of $84.76 and a 52-week high of $112.38. The company has a 50-day simple moving average of $94.80 and a 200 day simple moving average of $99.86. The company has a market capitalization of $18.69 billion, a P/E ratio of 48.02, a price-to-earnings-growth ratio of 2.41 and a beta of 1.00.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, topping the consensus estimate of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter in the previous year, the firm posted $0.87 EPS. Cooper Companies’s revenue was up 9.8% compared to the same quarter last year. Sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.